Mallinckrodt plc's Board announced the plan to spin off its generic pharmaceuticals and related businesses into a separate company named Par Health on October 21, 2025. Shareholders will need to follow specific procedures to receive shares or cash related to this spin-off, with a record date set for October 27, 2025.